U.S. Food and Drug Administration — Drug Shortages (FDA)
U.S. Food and Drug Administration — Drug Shortages is the official source of medicine shortage information for United States (Americas). Mederti checks its register daily and links every notice back to the original publication.
- Official register
- www.accessdata.fda.gov
- Country
- United States
- Notices tracked by Mederti
- 846
- Last checked
- 1 Nov 2026
Latest notices from FDA
- Ciprofloxacinsulfat (1:1) — active, medium, since 30 Oct 2026 (source)
- Metformin — active, medium, since 22 Oct 2026 (source)
- Molnupiravir — active, medium, since 20 Oct 2026 (source)
- Enoxaparina Sodica — active, medium, since 20 Oct 2026 (source)
- Leuprolide Acetate — active, medium, since 20 Oct 2026 (source)
- Lamivudine — active, medium, since 19 Oct 2026 (source)
- Vigabatrin — active, medium, since 16 Oct 2026 (source)
- Everolimus — active, medium, since 14 Oct 2026 (source)
- Dexmedetomidine Hydrochloride — active, medium, since 14 Oct 2026 (source)
- Felodipine — active, medium, since 7 Oct 2026 (source)
- Fluocinonide — active, medium, since 2 Oct 2026 (source)
- Ivermectin — active, medium, since 29 Sept 2026 (source)
- Arsenic Trioxide — active, medium, since 21 Sept 2026 (source)
- Rivastigmine — active, medium, since 18 Sept 2026 (source)
- Rivaroxaban — active, medium, since 18 Sept 2026 (source)
Every FDA notice, searchable and alertable
Search United States's full register alongside 50+ other countries — free for individual pharmacists and clinicians.
Create a free accountMederti is not affiliated with or endorsed by U.S. Food and Drug Administration — Drug Shortages. All notices remain the property of their publisher and are linked to the original source.